Related Experiment Video
Updated: Jul 16, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19
Adriana M Hung1,2, Shailja C Shah3,4, Alexander G Bick5
1Tennessee Valley Healthcare System, Nashville Campus, Nashville.
Insights
Individuals with African ancestry carrying two APOL1 risk variants face higher risks of acute kidney injury (AKI) and death following COVID-19 hospitalization. This association holds true even for those with normal kidney function before infection.
Area of Science:
- Nephrology
- Genetics
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) is a significant risk factor for acute kidney injury (AKI), leading to high mortality rates.
- Individuals of African ancestry with two copies of apolipoprotein L1 (APOL1) risk variants (G1 or G2) exhibit increased susceptibility to kidney disease.
Purpose of the Study:
- To investigate the association between APOL1 high-risk genotype and the risk of developing COVID-19-associated AKI and mortality.
- To determine if APOL1 risk variants influence AKI severity and death in patients hospitalized with COVID-19.
Main Methods:
- A retrospective cohort study involving 990 veterans of African ancestry hospitalized with COVID-19.
- Genetic information on APOL1 risk variants was analyzed, comparing the high-risk group (two risk variants) with the low-risk group (one or zero risk variants).
- Multivariable logistic regression was used to assess the association between APOL1 status and outcomes, adjusting for comorbidities and other risk factors. Subgroup analysis was performed for individuals with normal kidney function.
Main Results:
- The APOL1 high-risk group (12.6% of participants) showed significantly higher odds of developing AKI (OR, 1.95), increased AKI severity (OR, 2.03), and higher mortality (OR, 2.15) compared to the low-risk group.
- These associations remained significant even in the subgroup of patients with normal kidney function prior to hospitalization (AKI OR, 1.93).
- Overall, 39.6% of patients developed AKI, 14% had severe AKI, and 12.3% died.
Conclusions:
- APOL1 kidney risk variants are significantly associated with an increased risk of AKI, AKI severity, and death in individuals of African ancestry hospitalized with COVID-19.
- The findings highlight a genetic predisposition to severe kidney outcomes following COVID-19 infection in this population.
- The increased risk associated with APOL1 variants is evident even in individuals without pre-existing kidney impairment.
Importance:
Coronavirus disease 2019 (COVID-19) confers significant risk of acute kidney injury (AKI). Patients with COVID-19 with AKI have high mortality rates.
Objective:
Individuals with African ancestry with 2 copies of apolipoprotein L1 (APOL1) variants G1 or G2 (high-risk group) have significantly increased rates of kidney disease. We tested the hypothesis that the APOL1 high-risk group is associated with a higher-risk of COVID-19-associated AKI and death.
Design, Setting, And Participants:
This retrospective cohort study included 990 participants with African ancestry enrolled in the Million Veteran Program who were hospitalized with COVID-19 between March 2020 and January 2021 with available genetic information.
Exposures:
The primary exposure was having 2 APOL1 risk variants (RV) (APOL1 high-risk group), compared with having 1 or 0 risk variants (APOL1 low-risk group).
Main Outcomes And Measures:
The primary outcome was AKI. The secondary outcomes were stages of AKI severity and death. Multivariable logistic regression analyses adjusted for preexisting comorbidities, medications, and inpatient AKI risk factors; 10 principal components of ancestry were performed to study these associations. We performed a subgroup analysis in individuals with normal kidney function prior to hospitalization (estimated glomerular filtration rate ≥60 mL/min/1.73 m2).
Results:
Of the 990 participants with African ancestry, 905 (91.4%) were male with a median (IQR) age of 68 (60-73) years. Overall, 392 (39.6%) patients developed AKI, 141 (14%) developed stages 2 or 3 AKI, 28 (3%) required dialysis, and 122 (12.3%) died. One hundred twenty-five (12.6%) of the participants were in the APOL1 high-risk group. Patients categorized as APOL1 high-risk group had significantly higher odds of AKI (adjusted odds ratio [OR], 1.95; 95% CI, 1.27-3.02; P = .002), higher AKI severity stages (OR, 2.03; 95% CI, 1.37-2.99; P < .001), and death (OR, 2.15; 95% CI, 1.22-3.72; P = .007). The association with AKI persisted in the subgroup with normal kidney function (OR, 1.93; 95% CI, 1.15-3.26; P = .01). Data analysis was conducted between February 2021 and April 2021.
Conclusions And Relevance:
In this cohort study of veterans with African ancestry hospitalized with COVID-19 infection, APOL1 kidney risk variants were associated with higher odds of AKI, AKI severity, and death, even among individuals with prior normal kidney function.
More Related Videos
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

